The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Functional regulation of p73 and p63: development and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
Gong, J., Costanzo, A., Yang, H.-Q., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 930
Self-citationBasu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., & Jacks, T. (2002) · Nature · doi:10.1038/416560a · Cited by 802
Role for the p53 homologue p73 in E2F-1-induced apoptosis
Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. I., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., et al. (2000) · Nature · doi:10.1038/35036614 · Cited by 710
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00367-7 · Cited by 664
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S., Weichselbaum, R., & Kufe, D. (1999) · Nature · doi:10.1038/21704 · Cited by 578
p73: Friend or foe in tumorigenesis
Melino, G., De Laurenzi, V., & Vousden, K. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc861 · Cited by 560
Self-citationInteraction of c-Abl and p73α and their collaboration to induce apoptosis
Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 546
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
Marin, M. C., Jost, C. A., Brooks, L. A., Irwin, M. S., O'Nions, J., Tidy, J. A., James, N., McGregor, J. M., Harwood, C. A., Yulug, I. G., et al. (2000) · Nature Genetics · doi:10.1038/75586 · Cited by 515
On the shoulders of giants: p63, p73 and the rise of p53
Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 486
Bergamaschi, D., Gasco, M., Hiller, L., Sullivan, A., Syed, N., Trigiante, G., Yulug, I., Merlano, M., Numico, G., Comino, A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00079-5 · Cited by 449
p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells
Di Como, C. J., Gaiddon, C., & Prives, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1438 · Cited by 417
The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults
Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z., Blandino, G., Schneider, C., & Sal, G. D. (2002) · Nature · doi:10.1038/nature01120 · Cited by 414
Chemosensitivity linked to p73 function
Irwin, M. S., Kondo, K., Marin, M. C., Cheng, L. S., Hahn, W. C., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00078-3 · Cited by 408
Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity
De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M., & Melino, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1763 · Cited by 368
Self-citationHuman ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53
Grob, T. J., Novak, U., Maisse, C., Barcaroli, D., Lüthi, A. U., Pirnia, F., Hügli, B., Graber, H. U., De Laurenzi, V, Fey, M. F., et al. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400962 · Cited by 341
Self-citationDNA Damage-Dependent Acetylation of p73 Dictates the Selective Activation of Apoptotic Target Genes
Costanzo, A., Merlo, P., Pediconi, N., Fulco, M., Sartorelli, V., Cole, P. A., Fontemaggi, G., Fanciulli, M., Schiltz, L., Blandino, G., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00431-8 · Cited by 319
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E., & Moll, U. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020179 · Cited by 318
Dohn, M., Zhang, S., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204427 · Cited by 294
Differential regulation of E2F1 apoptotic target genes in response to DNA damage
Pediconi, N., Ianari, A., Costanzo, A., Belloni, L., Gallo, R., Cimino, L., Porcellini, A., Screpanti, I., Balsano, C., Alesse, E., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb998 · Cited by 266
Ghioni, P., Bolognese, F., Duijf, P. H. G., van Bokhoven, H., Mantovani, R., & Guerrini, L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8659-8668.2002 · Cited by 223
Wu, G., Nomoto, S., Hoque, M. O., Dracheva, T., Osada, M., Lee, C. R., Dong, S. M., Guo, Z., Benoit, N. E., Cohen, Y., et al. (2003) · PubMed · Cited by 221
Mdm2 binds p73α without targeting degradation
Bálint, E., Bates, S., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1202781 · Cited by 212
E2F and cell cycle control: a double-edged sword
Stevens, C., & La Thangue, N. B. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00054-7 · Cited by 205
A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism
Serber, Z., Lai, H. C., Yang, A., Ou, H. D., Sigal, M. S., Kelly, A. E., Darimont, B. D., Duijf, P. H. G., van Bokhoven, H., McKeon, F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8601-8611.2002 · Cited by 205
Langerød, A., Bukholm, I., Bregård, A., Lønning, P. E., Andersen, T. I., Rognum, T. O., Meling, G. I., Lothe, R. A., & Børresen‐Dale, A. (2002) · PubMed · Cited by 204
Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika, A., Kovalev, S. Y., Marchenko, N. D., & Moll, U. M. (1999) · PubMed · Cited by 191
ΔNp63 induces β-catenin nuclear accumulation and signaling
Patturajan, M., Nomoto, S., Sommer, M., Fomenkov, A., Hibi, K., Zangen, R., Poliak, N., Califano, J., Trink, B., Ratovitski, E., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00057-0 · Cited by 187
Induction of Neuronal Differentiation by p73 in a Neuroblastoma Cell Line
De Laurenzi, V., Raschellá, G., Barcaroli, D., Annicchiarico-Petruzzelli, M., Ranalli, M., Catani, M. V., Tanno, B., Costanzo, A., Levrero, M., & Melino, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15226 · Cited by 184
Self-citationExpression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients
Casciano, I., Mazzocco, K., Boni, L., Pagnan, G., Banelli, B., Allemanni, G., Ponzoni, M., Tonini, G. P., & Romani, M. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400993 · Cited by 182
Štros, M., Ozaki, T., Bačı́ková, A., Kageyama, H., & Nakagawara, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110233200 · Cited by 181
p73 Is Required for Survival and Maintenance of CNS Neurons
Pozniak, C. D., Barnabé‐Heider, F., Rymar, V. V., Lee, A. F., Sadikot, A. F., & Miller, F. D. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09800.2002 · Cited by 174
Promoter specificity and stability control of the p53-related protein p73
Lee, C., & Thangue, N. B. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202793 · Cited by 170
Shimodaira, H., Yoshioka-Yamashita, A., Kolodner, R. D., & Wang, J. Y. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438031100 · Cited by 168
Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
Dobbelstein, M., Wienzek, S., König, C., & Roth, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202512 · Cited by 161
Laurenzi, V. D., Catani, M., Costanzo, A., Terrinoni, A., Corazzari, M., Levrero, M., Knight, R. A., & Melino, G. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400521 · Cited by 160
Self-citationOncogenes Induce and Activate Endogenous p73 Protein
Zaika, A. I., Irwin, M. S., Sansome, C., & Moll, U. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005737200 · Cited by 143
MDM2 and MDMX bind and stabilize the p53-related protein p73
Ongkeko, W. M., Wang, X. Q., Siu, W. Y., Lau, A. W. S., Yamashita, K., Harris, A. L., Cox, L. S., & Poon, R. Y. C. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80367-4 · Cited by 134
Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans
van Bokhoven, H., & McKeon, F. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02260-2 · Cited by 122
p53 associates with and targets ΔNp63 into a protein degradation pathway
Ratovitski, E. A., Patturajan, M., Hibi, K., Trink, B., Yamaguchi, K., & Sidransky, D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1817 · Cited by 117
Regulation of p73 by c-Abl through the p38 MAP kinase pathway
Sánchez‐Prieto, R., Lobo, V. J. S.-A., Servitja, J., & Gutkind, J. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205134 · Cited by 113
Jung, M.-S., Yun, J., Chae, H., Kim, J., Kim, S., Choi, T.-S., & Shin, D. Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204748 · Cited by 101
Calabrò, V., Mansueto, G., Parisi, T., Vivo, M., Calogero, R., & Mantia, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107173200 · Cited by 94
p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression
Uramoto, H., Izumi, H., Ise, T., Tada, M., Uchiumi, T., Kuwano, M., Yasumoto, K., Funa, K., & Kohno, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200266200 · Cited by 92
SSRP1 functions as a co‐activator of the transcriptional activator p63
Zeng, S. X., Dai, M., Keller, D. M., & Lu, H. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf540 · Cited by 89
Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation
Ohtsuka, T., Ryu, H., Minamishima, Y. A., Ryo, A., & Lee, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206306 · Cited by 88
Binding of the C-terminal Sterile α Motif (SAM) Domain of Human p73 to Lipid Membranes
Barrera, F. N., Poveda, J. A., González-Ros, J. M., & Neira, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307846200 · Cited by 84
Regulation of p63 Function by Mdm2 and MdmX
Kadakia, M., Slader, C., & Berberich, S. J. (2001) · DNA and Cell Biology · doi:10.1089/10445490152122433 · Cited by 83
Watanabe, K., Ozaki, T., Nakagawa, T., Miyazaki, K., Takahashi, M., Hosoda, M., Hayashi, S., Todo, S., & Nakagawara, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111281200 · Cited by 83
Comparative Analysis of P73 and P53 Regulation and Effector Functions
Li, F., Lee, S. W., & Aaronson, S. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.4.823 · Cited by 82
Hdmx and Mdm2 can repress transcription activation by p53 but not by p63
Little, N. A., & Jochemsen, A. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204615 · Cited by 73
Kim, E. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg741 · Cited by 67
Nuclear Import and Export Signals in Control of the p53-related Protein p73
Inoue, T. M., Stuart, J., Leno, R., & Maki, C. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200248200 · Cited by 66
Gaiddon, C., Lokshin, M., Groß, I., Levasseur, D., Taya, Y., Loeffler, J., & Prives, C. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300251200 · Cited by 65
Physical Interaction between Wilms Tumor 1 and p73 Proteins Modulates Their Functions
Scharnhorst, V., Dekker, P., van der Eb, A. J., & Jochemsen, A. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10202 · Cited by 64
Differential regulation of p63 and p73 expression
Waltermann, A., Kartasheva, N. N., & Dobbelstein, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206859 · Cited by 59
Uramoto, H., Izumi, H., Nagatani, G., Ohmori, H., Nagasue, N., Ise, T., Yoshida, T., Yasumoto, K., & Kohno, K. (2003) · Biochemical Journal · doi:10.1042/bj20021646 · Cited by 58
Budhram-Mahadeo, V. S., Morris, P. J., & Latchman, D. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205842 · Cited by 53
Ozaki, T., Watanabe, K., Nakagawa, T., Miyazaki, K., Takahashi, M., & Nakagawara, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206382 · Cited by 48
p73 Is Regulated by Phosphorylation at the G2/M Transition
Fulco, M., Costanzo, A., Merlo, P., Mangiacasale, R., Strano, S., Blandino, G., Balsano, C., Lavia, P., & Levrero, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304921200 · Cited by 42
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function
Vella, V., Zhu, J., Frasca, F., Li, C.-Y., Vigneri, P. G., Vigneri, R., & Wang, J. Y. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301962200 · Cited by 37
Brooks, L., Sullivan, A., O’Nions, J., Bell, A., Dunne, B., TIDY, J. A., Evans, D. J., Osin, P., Vousden, K. H., Gusterson, B. A., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600033 · Cited by 34
pRb inactivation in senescent cells leads to an E2F-dependent apoptosis requiring p73.
Alexander, K., Yang, H.-S., & Hinds, P. W. (2003) · PubMed · Cited by 24
Kim, K., Kim, T.-S., Kang, K., & Choi, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204839 · Cited by 15
Whitman, M., & McKeon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00317-9 · Cited by 6
Cited by
p53 isoforms can regulate p53 transcriptional activity
Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P. (2005) · Genes & Development · doi:10.1101/gad.1339905 · Cited by 810
The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development
Bernassola, F., Karin, M., Ciechanover, A., & Melino, G. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.001 · Cited by 541
Self-citationMurray-Zmijewski, F., Lane, D. P., & Bourdon, J.-C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 523
Regulation of gene-activation pathways by PIAS proteins in the immune system
Shuai, K., & Liu, B. (2005) · Nature Reviews Immunology · doi:10.1038/nri1667 · Cited by 447
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
Rocco, J. W., Leong, C.-O., Kuperwasser, N., DeYoung, M. P., & Ellisen, L. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.013 · Cited by 433
Metadata
- Authors
- Melino, G.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 28
- Issue
- 12
- Pages
- 663-670
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W2034918846
- Cited by
- 278
- References
- 72
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.